Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Lennartz

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Cancer Medicine|March 13, 2026
Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 TumorsNina Schraps, Anne Menz, Florian Viehweger, et al.
European Urology|November 7, 2015
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy SpecimensGuido Sauter, Stefan Steurer, Till Sebastian Clauditz, et al.
Diagnostics (Basel, Switzerland)|October 28, 2023
Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer TissuesLaura Sophie Tribian, Maximilian Lennartz, Doris Höflmayer, et al.
Human Pathology|March 7, 2025
Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entitiesFlorian Viehweger, Justus Gusinde, Nicolai Leege, et al.
Cancer Medicine|November 13, 2024
Prevalence and Significance of AGR2 Expression in Human CancerNina Schraps, Jacob Constantin Port, Anne Menz, et al.
The American Journal of Surgical Pathology|April 22, 2024
TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor EntitiesMaximilian Lennartz, Neele Löhr, Doris Höflmayer, et al.
BJUI Compass|June 14, 2024
CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease courseHenning Plage, Kira Furlano, Jörg Neymeyer, et al.
Pathologica|July 8, 2025
KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladderFlorian Viehweger, Natalia Gorbokon, Seyma Büyücek, et al.
Frontiers in Oncology|January 29, 2024
Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomasJan H Müller, Henning Plage, Sefer Elezkurtaj, et al.
European Urology|February 21, 2024
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial CancerNicolaus F Debatin, Elena Bady, Tim Mandelkow, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Cancer Medicine|March 13, 2026
Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 TumorsNina Schraps, Anne Menz, Florian Viehweger, et al.
European Urology|November 7, 2015
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy SpecimensGuido Sauter, Stefan Steurer, Till Sebastian Clauditz, et al.
Diagnostics (Basel, Switzerland)|October 28, 2023
Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer TissuesLaura Sophie Tribian, Maximilian Lennartz, Doris Höflmayer, et al.
Human Pathology|March 7, 2025
Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entitiesFlorian Viehweger, Justus Gusinde, Nicolai Leege, et al.
Cancer Medicine|November 13, 2024
Prevalence and Significance of AGR2 Expression in Human CancerNina Schraps, Jacob Constantin Port, Anne Menz, et al.
The American Journal of Surgical Pathology|April 22, 2024
TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor EntitiesMaximilian Lennartz, Neele Löhr, Doris Höflmayer, et al.
BJUI Compass|June 14, 2024
CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease courseHenning Plage, Kira Furlano, Jörg Neymeyer, et al.
Pathologica|July 8, 2025
KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladderFlorian Viehweger, Natalia Gorbokon, Seyma Büyücek, et al.
Frontiers in Oncology|January 29, 2024
Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomasJan H Müller, Henning Plage, Sefer Elezkurtaj, et al.
European Urology|February 21, 2024
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial CancerNicolaus F Debatin, Elena Bady, Tim Mandelkow, et al.
Pageof 12